Sana Bio (SANA) Stock Forecast, Price Target & Predictions


OverviewOwnershipFinancialsChart

SANA Stock Forecast


Sana Bio (SANA) stock forecast, based on 8 Wall Street analysts, predicts a 12-month average price target of $8.00, with a high of $8.00 and a low of $8.00. This represents a 406.33% increase from the last price of $1.58.

$1 $3 $5 $7 $9 $11 High: $8 Avg: $8 Low: $8 Last Closed Price: $1.58

SANA Stock Rating


Sana Bio stock's rating consensus is Buy, based on 8 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (62.50%), 3 Hold (37.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 8 0 3 5 Strong Sell Sell Hold Buy Strong Buy

SANA Price Target Upside V Benchmarks


TypeNameUpside
StockSana Bio406.33%
SectorHealthcare Stocks 33.91%
IndustryBiotech Stocks 83.49%

Price Target Trends


1M3M12M
# Anlaysts--1
Avg Price Target--$8.00
Last Closing Price$1.58$1.58$1.58
Upside/Downside--406.33%
Ratings Trends

DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 25341--8
Mar, 25232--7
Feb, 25232--7
Jan, 25233--8
Dec, 24223--7
Analyst Price Target Forecasts

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 05, 2024Emily BodnarH.C. Wainwright$8.00$3.39135.99%406.33%
Jan 16, 2024Emily BodnarH.C. Wainwright$12.00$6.3688.68%659.49%
Analyst Rating Forecasts

DateCompanyPrevious RatingNew RatingRating Change
Jan 11, 2025Morgan StanleyOverweightOverweighthold
Jan 08, 2025CitigroupBuyBuyhold
Jan 08, 2025H.C. WainwrightBuyBuyhold
Nov 05, 2024H.C. WainwrightBuyBuyhold
Nov 05, 2024JMP SecuritiesPerformdowngrade
Aug 09, 2024CitigroupBuyBuyhold
Jun 26, 2024Rodman & RenshawBuyinitialise
Jan 16, 2024H.C. WainwrightBuyupgrade

Financial Forecast


EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.46$-1.16----
Avg Forecast$-1.54$-1.20$-0.87$-0.82$-1.17$-1.27
High Forecast$-1.51$-1.14$-0.71$-0.64$-1.02$-1.27
Low Forecast$-1.57$-1.27$-1.12$-0.96$-1.31$-1.27
Surprise %-5.19%-3.33%----

Revenue Forecast

$5M $14M $23M $32M $41M $50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast----$6.95M$45.53M
High Forecast----$6.95M$45.53M
Low Forecast----$6.95M$45.53M
Surprise %------

Net Income Forecast

$-350M $-300M $-250M $-200M $-150M $-100M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-283.25M$-266.76M----
Avg Forecast$-299.34M$-234.76M$-198.23M$-155.20M$-226.97M$-247.07M
High Forecast$-292.83M$-222.40M$-137.76M$-124.35M$-198.91M$-247.07M
Low Forecast$-305.84M$-247.11M$-218.79M$-186.06M$-255.02M$-247.07M
Surprise %-5.37%13.63%----

SANA Forecast FAQ


Is Sana Bio stock a buy?

Sana Bio stock has a consensus rating of Buy, based on 8 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Sana Bio is a favorable investment for most analysts.

What is Sana Bio's price target?

Sana Bio's price target, set by 8 Wall Street analysts, averages $8 over the next 12 months. The price target range spans from $8 at the low end to $8 at the high end, suggesting a potential 406.33% change from the previous closing price of $1.58.

How does Sana Bio stock forecast compare to its benchmarks?

Sana Bio's stock forecast shows a 406.33% upside, outperforming the average forecast for the healthcare stocks sector (33.91%) and outperforming the biotech stocks industry (83.49%).

What is the breakdown of analyst ratings for Sana Bio over the past three months?

  • April 2025: 37.50% Strong Buy, 50.00% Buy, 12.50% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 28.57% Strong Buy, 42.86% Buy, 28.57% Hold, 0% Sell, 0% Strong Sell.
  • February 2025: 28.57% Strong Buy, 42.86% Buy, 28.57% Hold, 0% Sell, 0% Strong Sell.

What is Sana Bio’s EPS forecast?

Sana Bio's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.87, marking a -25.00% decrease from the reported $-1.16 in 2024. Estimates for the following years are $-0.82 in 2026, $-1.17 in 2027, and $-1.27 in 2028.

What is Sana Bio’s revenue forecast?

Sana Bio's average annual revenue forecast for its fiscal year ending in December 2025 is $0, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $0, followed by $6.95M for 2027, and $45.53M for 2028.

What is Sana Bio’s net income forecast?

Sana Bio's net income forecast for the fiscal year ending in December 2025 stands at $-198M, representing a -25.69% decrease from the reported $-267M in 2024. Projections indicate $-155M in 2026, $-227M in 2027, and $-247M in 2028.